FOI release

Kavigale (Sipavibart) LAAB Inquiry (FOI)

This request was refused in full, so we didn't provide the information the requester asked for. This may include information where we can neither confirm nor deny that we hold it.

Case reference FOI2025/00537

Received 30 May 2025

Published 5 August 2025

Request

I am looking for an update regarding the Kavigale (Sipavibart) LAAB for the UK only. Have Astrazeneca submitted the full Kavigale (Sipavibart) trial results to the UK MHRA and NICE for approval? If so: 1. What date did the data all get submitted? 2. Is this vaccine under fast track? If so, which fast track? 3. How long do such vaccines under fast track take? 4. ⁠Once a vaccine is approved, how long does it take for it to be rolled out for administration?

Response

see attached

Documents

• FOI2025_00537 redacted for publication.pdf (116.8 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.